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Despite the efforts that have been made, it is still difﬁcult to predict
preeclampsia and itsmorbidity [1]. Flow-mediated dilatation (FMD) is a
technique that has been employed to investigate the role of vascular
alterations in preeclampsia [2]. Our hypothesis is that FMD may be
useful as a clinical test prognostic marker, specially associated with
routine laboratorial exams. We therefore studied the association of
endothelial dysfunction, assessed by FMD, with preeclampsia morbidity.
The study was approved by the Research Ethics Committee of
Pontifícia Universidade Católica do Rio Grande do Sul (Protocol 368/11),
andwritten consentwas obtained fromall participants before inclusion.
This is a cohort study that enrolled women with preeclampsia at the
diagnostic moment, accompanied until delivery. Womenwere grouped
according to preeclampsia outcomes dividing into women with or
without complications. Complicated preeclampsia was considered
when any of the following occurred: HELLP syndrome (hemolysis,
elevated liver enzymes, low platelets), eclampsia, abruptio placentae,
mother's Intensive Care Unit admission, maternal death, early pre-
maturity (delivery before 34 weeks gestation), severe growth restric-
tion (percentile b 5), newborn lighter than 2 kg, APGAR Score b7 in the
ﬁfth minute, need of Neonatal Intensive Care Unit admission or
stillbirth. Twin pregnancy, women who were in labor on preeclampsia
diagnosis and patients who withdraw consent were excluded.
Endothelial functionwas evaluated by brachial artery FMD, using the
protocol adapted fromCelermajer DS, et al. [3]. FMDwasmeasured in the
ﬁrst day of diagnosis and all patients rested for 10 min before baseline
evaluation. None smoked cigarettes or drank coffee for at least 8 h before
the ultrasound exam. This protocol has previously been used in our
hospital [4]. Ultrasounds were performed by two observers. Intraobser-
ver variability was 6.2% and 6.8%. Intra-class coefﬁcient was 0.91
between observers.
Sample size was calculated to detect a difference of one standard
deviation in the FMD (90% power and alfa 0.05), estimating at least 22
subjects by group.
The study included 66 women with preeclampsia and two were
excluded, one twin pregnancy and one that delivered in another city.
The remaining 64 subjects were analyzed, 26 developed complicated
preeclampsia and 38 had preeclampsia without associated morbidities.
Clinical characteristics, laboratory and Doppler ultrasound values are
summarized in Table 1.
FMD in complicated preeclampsia group was 7.44% (IQR 2.20–
13.34%) while in preeclampsia group was 11.80% (IQR 5.36–16.66%)
(P= 0.03) as shows Fig. 1a. To better evaluate FMD association with
morbidity, a composite ofmajor outcomes (HELLP syndrome, eclampsia
or stillbirth) was selected from the complicated preeclampsia group
and 13women ﬁt these criteria. FMDwas 2.84% (IQR 0.00–7.22%) in this
sub-group compared to 11.90% (IQR 5.56–16.62%) of all other women
(P b 0,001) (Fig. 1b). At last, a cutoff value of FMD b4.5% was used for
risk estimation [5]. It was associated with anOdds Ratio (OR) of 3.79 (IC
95% 1.23–11.70) for complicated preeclampsia and an OR of 15.55 (IC
95% 3.55–68.16) for predicting the composite major outcomes.
Endothelial dysfunction evaluated through FMD is known to be
present in preeclampsia patients [2,4,6,7], but the association with
severity of the disease has been poorly investigated. The present study
demonstrates that decreased FMD may be linked directly to morbidity
of preeclampsia. These results are in agreement with a study that
evaluated preeclampsia and severe preeclampsia, showing worst
endothelial function on the severe group, even though the authors
haven't made a statistical comparison [2].
Endothelial dysfunction is thought to be one of the mechanisms
involving preeclampsia manifestations (hypertension and proteinuria).
While in normal pregnancy FMD increases throughout pregnancy [8], in
womenwith preeclampsia it is reduced [6]. Also, FMDwas altered even
before the onset of the disease [2,7]. We tested its association with
disease severity, supported by the theory of impaired nitric oxide
bioavailability in preeclampsia [9,10]. Our results have shown that FMD
Table 1






Age (years)a 27.5 ± 6.4 26.2 ± 7.1 0.41
Chronic hypertension n (%)b 10 (26.3) 10 (38.5) 0.29
Cigarette smoke n (%)b 4 (10.5) 6 (23.1) 0.49
Nulliparity n (%)b 16 (42.1) 13 (50.0) 0.61
SBP (mmHg) a 156 ± 17 167 ± 18 0.012
DBP (mmHg) a 98 ± 12 104 ± 13 0.045
GA diagnosis (weeks)a 35.6 ± 1.9 29.4 ± 4.4 b0.001
GA at term (weeks)a 37.5 ± 1.5 31.0 ± 4.4 b0.001
Birth weight (g)a 3.037 ± 546 1.482 ± 870 b0.001
P/C Ratio c 0.49 (0.27–0.71) 0.67 (0.36–4.67) 0.038
Proteinuria 24 h (mg) c 365 (295–474) 673 (471–2.614) 0.001
Uric Acid (mg/dL) a 4.5 ± 1.2 5.3 ± 1.4 0.013
AST (units/L)c 21 (17–26) 40 (24–109) b0.001
ALT (units/L)c 19 (14–24) 36 (23–101) b0.001
LDH (units/L)c 467 (405–558) 718 (546–1.190) b0.001
Creatinine (mg/dL)a 0.71 ± 0.15 0.89 ± 0.28 0.02
Platelets (×1000/mcL)a 219 ± 65 169 ± 68 0.005
Uterine artery RIa 0.50 ± 0.10 0.68 ± 0.18 b0.001
Umbilical artery RIa 0.57 ± 0.08 0.70 ± 0.12 b0.001
Median cerebral artery RIa 0.81 ± 0.08 0.79 ± 0.07 0.47
FMD (%) c 11.80 (5.36–16.66) 7.44 (2.20–13.34) 0.034
GA-gestational age; AST-aspartate aminotransferase; ALT-alanine aminotransferase;
LDH-lactate dehydrogenase; RI-resistance index; FMD-ﬂow mediated dilatation; P/C
ratio-proteinuria/creatininuria ratio; SBP-systolic blood pressure; DBP-diastolic blood
pressure.
a Mean ± standard deviation and Student t test.
b Percentual and Qui-square test.
c Median (IQR 25–75) and Mann Whitney test.
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Laboratório de Nefrologia, Instituto de Pesquisas Biomédicas, Porto Alegre, ZIP code:
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1 This author takes responsibility for all aspects of the reliability and freedom from
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is impaired in complicated preeclampsia and it was reassured by the
fact that in women with the worst outcomes it was remarkably lower.
Furthermore, FMDof equal or less than 4.5% seems to be a reliable cutoff
point associated with a four-fold increment of complications and a 15
fold increased risk ofmajor outcomes. It is interesting to remember that
low cutoff point should only be used in a set of patients with known
impaired endothelial function [5], data is lacking to determine cutoff
point for low risk population. Despite the fact that our study was not
meant to determine prediction power, a preliminary analysis of the ROC
curve suggests that FMD might be a weak prognostic marker for
preeclampsia complications (AUC= 0.66; IC 95% 0.52–0.79). When
used to predict major outcomes AUC increases markedly (AUC= 0.84;
IC 95% 0.73–0.96).
Preeclampsia has many clinical presentations, it is a multisystemic
disease that affects organs in different proportion, as illustrated by cases
of preeclampsia without proteinuria or hypertension. FMD of brachial
artery evaluates only one site, brachial artery endothelium, and
sometimes it might not reﬂect the severity of whole disease. The
variety of damage that can be caused by preeclampsia may be a
limitation for this method to predict the disease and complications.
FMD of brachial artery is decreased in complicated preeclampsia in
comparisonwith preeclampsiawithout complications. Severe endothe-
lial dysfunction, measured by FMD test, is associated with higher risk of
poor outcomes and may predict complications of the disease.
Preeclampsia etiology and pathophysiology are not fully understood
and probably this is the reason a speciﬁc predictor and prognostic
marker haven't been found. Our ﬁndings support the evidence of
endothelial dysfunction as a key mechanism for preeclampsia compli-
cations and also that FMD may be a prognostic marker.
Matias CostaVieira, Marta Ribeiro Hentschke had support from CAPES
(CAPES—Coordenação de Aperfeiçoamento de Pessoal de Nível Superior).
Poli-de-Figueiredo is a CNPq (Conselho Nacional de Desenvolvimento
Cientíﬁco e Tecnológico) researcher.
References
[1] Ganzevoort W, Rep A, de Vries JI, Bonsel GJ, Wolf H. Prediction of maternal
complications and adverse infant outcome at admission for temporizing manage-
ment of early-onset severe hypertensive disorders of pregnancy. Am J Obstet Gynecol
2006;195(2):495–503.
[2] Noori M, Donald AE, Angelakopoulou A, Hingorani AD, Williams DJ. Prospective
study of placental angiogenic factors andmaternal vascular function before and after
preeclampsia and gestational hypertension. Circulation 2010;122(5):478–87.
[3] Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial
dysfunction in children and adults at risk of atherosclerosis. Lancet
1992;340(8828):1111–5.
[4] Filho EV, Mohr C, Filho BJ, et al. Flow-mediated dilatation in the differential diagnosis of
preeclampsia syndrome. Arq Bras Cardiol 2010;94(2):182–6 [95-200, 185-9].
[5] Yinon Y, Kingdom JC, Odutayo A, et al. Vascular dysfunction inwomenwith a history of
preeclampsia and intrauterine growth restriction: insights into future vascular risk.
Circulation 2010;122(18):1846–53.
[6] Adali E, Kurdoglu M, Adali F, Cim N, Yildizhan R, Kolusari A. The relationship between
brachial artery ﬂow-mediated dilatation, high sensitivity C-reactive protein, and uterine
artery Doppler velocimetry in women with pre-eclampsia. J Clin Ultrasound
2011;39(4):191–7.
[7] Kamat R, Jain V, Bahl A. Serial estimation of ﬂowmediated dilatation inwomen at risk of
hypertensive disorders of pregnancy. Int J Cardiol 2011;149(1):17–22.
[8] Savvidou MD, Kametas NA, Donald AE, Nicolaides KH. Non-invasive assessment of
endothelial function in normal pregnancy. Ultrasound Obstet Gynecol
2000;15(6):502–7.
[9] Matsubara K, Matsubara Y, Hyodo S, Katayama T, Ito M. Role of nitric oxide and
reactive oxygen species in the pathogenesis of preeclampsia. J Obstet Gynaecol Res
2010;36(2):239–47.
[10] Pinheiro da Costa BE, Scocco C, Poli de Figueiredo CE, Guimaraes JA. Increased serum
phosphodiesterase activity in women with pre-eclampsia. BJOG 2006;113(5):577–9.
0167-5273/$ – see front matter © 2013 Elsevier Ireland Ltd. All rights reserved.
http://dx.doi.org/10.1016/j.ijcard.2013.05.014
Fig. 1. Comparison of FMD between groups.
4425Letters to the Editor
